International milestones

First export to Algeria.

Start of international expansion: the company entered the markets of Kazakhstan, Russia, Azerbaijan and Lebanon and began exporting to these countries.

Abdi İbrahim became the first Turkish company to be listed among the “World’s 100 Largest Pharmaceutical Companies”. The same year, it established its own sales and marketing organisation in Algeria.

Sales and marketing team established in Azerbaijan.

First shipment to Europe — to France. Abdi Farma established in Portugal and the first shipment made. Sales and marketing of Abdi İbrahim-branded products began in Iraq via distributors. 60% stake acquired in Kazakhstan’s Global Pharm and Abdi Ibrahim Global Pharm (AIGP) founded. First UN Global Compact progress report published.

Sales of Abdi İbrahim products began in Albania via a distributor.

Abdi Farma obtained licences to sell Abdi İbrahim products in nine European countries.

Abdi İbrahim Remede Pharma (AIRP) founded in Algeria as a 50:50 joint venture, and investment begun in the country’s most modern pharmaceutical plant. First licence in Canada.

AIGP production complex in Kazakhstan began operations. First shipment to South America — to Colombia. Sales and marketing team established in Bosnia and Herzegovina. First export of a biotech product — to Algeria. First shipment of a liquid dosage form — to Denmark and Sweden.

AIGP made its first export sale — to Afghanistan. First licence in the Gulf countries.

AIRP, the most modern pharmaceutical plant in Algeria, started GMP-certified production.

First local product licences obtained in Algeria.

First contract manufacturing (CMO) project launched in Algeria. International revenue reached USD 100 million.